Tiny needle, big hope: new eye surgery trial for sudden blindness
NCT ID NCT07151755
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This trial tests a new procedure for people who suddenly lose vision due to a blocked artery in the eye. Surgeons will use a tiny microneedle to deliver clot-busting medicine directly into the artery during eye surgery. The study will compare this approach to standard care in 24 participants, tracking vision recovery over one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
thrombolytic agent delivered via microneedle
What this could lead to
If it works, this could offer a new way to restore vision after a blockage in the eye's main artery.
What could go wrong
This is a very small, early-stage trial with only 24 people. The procedure is invasive and carries risks like bleeding or infection. Success is not guaranteed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL RETINAL ARTERY OCCLUSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Eye Center of the Second Affiliated Hospital of Zhejiang University
RECRUITINGHangzhou, Zhejiang, 310058, China
Contact Phone: •••-•••-•••• Email: •••••@•••••